Skip to content

Utah Medical Products UTMD Contract Assets, Net

Contract Assets, Net at other companies

CorMedix logo
CorMedixCRMD
$256K

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInventory.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's contract assets, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's contract assets, net?
Utah Medical Products (UTMD) reported contract assets, net of $254K in Q4 2025.
How has Utah Medical Products's contract assets, net changed year-over-year?
Utah Medical Products's contract assets, net decreased by 5.9% year-over-year, from $270K to $254K.
What is the long-term trend for Utah Medical Products's contract assets, net?
Over 5 years (2020 to 2025), Utah Medical Products's contract assets, net has grown at a 24.2% compound annual growth rate (CAGR), from $86K to $254K.
What does contract assets, net mean?
This represents the company's right to consideration in exchange for goods or services that have been transferred to a customer but for which the right to payment is conditional on something other than the passage of time. It is a key indicator of revenue recognition progress before formal invoicing occurs.